TSUMUGU Holdings, Inc. (SPSE:3055)

Japan · Delayed Price · Currency is JPY

946.00

+23.00 (2.49%)

At close: Oct 30, 2026

Market Cap	19.45B +3.5%
Revenue (ttm)	305.97B +4.4%
Net Income	1.41B -46.2%
EPS	67.91 -45.3%
Shares Out	20.56M
PE Ratio	13.93
Forward PE	n/a
Dividend	20.00 (2.11%)
Ex-Dividend Date	Sep 29, 2026

Volume	200
Open	946.00
Previous Close	923.00
Day's Range	946.00 - 946.00
52-Week Range	856.00 - 1,000.00
Beta	0.00
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About TSUMUGU Holdings

TSUMUGU Holdings, Inc. engages in the wholesale of pharmaceutical products and medical devices in Japan. It also sells medical devices, such as therapeutic and facility equipment, image diagnostic equipment, optical equipment, artificial organ-related equipment, bioinformation-related equipment, physical therapy equipment, and testing equipment, as well as general-purpose products, such as syringes to implants used in orthopedic surgery. In addition, the company operates pharmacies in Hokkaido and nursing care facilities; rental wheelchairs and... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 2006

Employees 1,591

Stock Exchange Sapporo Stock Exchange

Ticker Symbol 3055

Full Company Profile

Financial Performance

In fiscal year 2026, TSUMUGU Holdings's revenue was 303.67 billion, an increase of 4.88% compared to the previous year's 289.53 billion. Earnings were 1.68 billion, a decrease of -31.92%.

Financial Statements